BRUSSELS and PRAGUE, April 25, 2024 /PRNewswire/ -- Zentiva, a Pan-European pharmaceutical company, joined the inaugural launch of the EU's Critical Medicines Alliance, held on April 24-25 in Brussels. This significant event, organized by DG HERA and the Belgian Presidency, convened leaders from across the healthcare industry to address the challenges of medicine supply resilience in the European Union.
Prague, Aug. 1, 2023 /PRNewswire/ -- Zentiva is a leading manufacturer and supplier of high-quality and affordable medicines to more than 100 million people in Europe and beyond. With sustainability embedded into its business strategy, the company fulfilled its 2022 sustainability goals and implemented actions in 3 pillars: People, Partners and Planet.
STEFFEN SALTOFTE APPOINTED AS CEO OF ZENTIVA
Advent, CVC Are Among Suitors for €3 Billion Viatris OTC Assets
Zentiva recognized as Top Employer in Czech Republic & Romania for the second year!
PRAGUE, Jan. 9, 2023 /PRNewswire/ -- Zentiva is pleased to announce that we have extended our strategic partnership with Adalvo, signing a licensing deal for three molecules, within Europe.
Successful pivotal bioequivalence study results on Omeprazole Immediate Release Capsules
Zentiva completes major product acquisition from Tillomed Spain
Biocon Limited (BSE code: 532523, NSE: BIOCON), an innovation-led global biopharmaceutical company, today announced the signing of a semi-exclusive partnership agreement with Zentiva, a leading pharmaceutical company in Europe, for the commercialization of its vertically integrated, complex formulation, Liraglutide, a drug-device combination for the treatment and management of Type 2 diabetes and obesity.
Zentiva opens its doors for the young talents of the Big Step project